We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CMNDF market cap is 4.8M. The company's latest EPS is USD -14.2026 and P/E is -0.56.
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 141k |
Operating Income | -41k | -14k | -3.68M | -6.66M | -3.83M |
Net Income | -105k | -233k | -3.9M | -9.41M | -8.62M |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | USD (US$) | |
Total Assets | 178k | 513k | 5.16M | 1.13M | 5.95M |
Total Liabilities | 44k | 13k | 357k | 2.64M | 4.97M |
Total Equity | 134k | 500k | 4.8M | -1.51M | 983k |
Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | USD (US$) | |
Operating | -63k | -264k | -2.84M | -5.08M | -6.3M |
Investing | -10k | -6k | -251k | -8k | -26k |
Financing | N/A | 599k | 7.36M | 699k | 11.66M |
Market Cap | 4.8M |
Price to Earnings Ratio | -0.56 |
Price to Sales Ratio | 34.01 |
Price to Cash Ratio | 0.88 |
Price to Book Ratio | 4.88 |
Dividend Yield | - |
Shares Outstanding | 607k |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 7.71 (70.09%) |
Company Name | Clearmind Medicine Inc (PK) |
Address |
suite 101, 1220 west 6th avenue vancouver, british columbia V6H 1A5 |
Website | https://www.clearmindmedicine.com |
Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions